ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 99 filers reported holding ADAMAS PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.92 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $20,000 | +5.3% | 4,814 | 0.0% | 0.00% | – |
| Q3 2020 | $19,000 | +58.3% | 4,814 | 0.0% | 0.00% | – |
| Q2 2020 | $12,000 | -7.7% | 4,814 | 0.0% | 0.00% | – |
| Q1 2020 | $13,000 | +1200.0% | 4,814 | +1103.5% | 0.00% | – |
| Q4 2019 | $1,000 | -66.7% | 400 | 0.0% | 0.00% | – |
| Q3 2019 | $3,000 | -98.3% | 400 | -92.2% | 0.00% | – |
| Q4 2017 | $181,000 | +9.0% | 5,152 | -34.5% | 0.00% | – |
| Q3 2017 | $166,000 | +14.5% | 7,863 | -4.9% | 0.00% | – |
| Q2 2017 | $145,000 | -62.4% | 8,272 | -62.5% | 0.00% | -100.0% |
| Q1 2017 | $386,000 | -17.7% | 22,049 | -18.1% | 0.00% | 0.0% |
| Q4 2016 | $469,000 | – | 26,917 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,601,351 | $43,963,000 | 9.03% |
| Granite Point Capital Management, L.P. | 256,031 | $4,327,000 | 3.45% |
| Opaleye Management Inc. | 285,000 | $4,817,000 | 2.84% |
| Brenner West Capital Advisors | 1,221,463 | $20,643,000 | 2.28% |
| ARMISTICE CAPITAL, LLC | 536,000 | $9,058,000 | 2.14% |
| NEXTHERA CAPITAL LP | 151,670 | $2,563,000 | 1.50% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 185,234 | $3,130,000 | 1.41% |
| Cheyne Capital Management (UK) LLP | 144,765 | $2,448,000 | 1.38% |
| SPHERA FUNDS MANAGEMENT LTD. | 270,000 | $4,563,000 | 1.16% |
| Mosaic Family Wealth, LLC | 123,314 | $2,084,000 | 0.96% |